Orally Active Nanoformulation of Lisofylline and Composition Thereof
Inventors:
Dr. Anupama Mittal , Kishan Italiya Samjibhai, Samrat Mazumdar, Prof. Deepak Chitkara
There's a need for an improved drug delivery system to enhance oral bioavailability and stability while reducing discomfort associated with parenteral administration.
The invention presents a biodegradable polymeric nanoformulation for enhanced oral bioavailability and stability, particularly beneficial for treating chronic disorders like Type 1 Diabetes.
The invention introduces a novel composition and method for formulating a polymeric nanoformulation, incorporating specific amphiphilic block copolymer and lisofylline-fatty acid conjugate ratios, addressing challenges in drug delivery efficiency and patient convenience.
Potential Indian Clients: Pharmaceutical companies, research institutions
Current TRL: NA
Funded by: NA
IPC: A61K
Domain: Pharmaceutical nanoformulation
This website uses cookies or similar technologies, to enhance your browsing experience.